Accessibility Menu
Smith & Nephew Plc logo

Smith & Nephew Plc(LSE) SN

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1980)+19,124%
5 Year-25%
1 Year-24%
1 Month-6%
N/A
Smith & Nephew Plc last closing stock price
MetricPriceDate
Last closeGBX 1,052.002026-09-03
Smith & Nephew Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.91%GBX 1,072.502026-08-27
1 month-6.24%GBX 1,122.002026-08-04
3 month-8.28%GBX 1,147.002026-06-05
Year to date-15.06%GBX 1,238.502025-12-31
1 year-24.26%GBX 1,389.002025-09-03
3 year-0.28%GBX 1,055.002023-09-04
5 year-24.83%GBX 1,399.502021-09-03
Since inception+19,123.69%GBX 0.061980-01-03

Smith & Nephew Plc Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.35B

Net Income (TTM)

$1.14B

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Feb 23, 2027

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Smith & Nephew plc is a global leader in medical technology, specializing in the development, manufacturing, and marketing of innovative medical devices. The company focuses on orthopaedics, sports medicine, and advanced wound management, providing solutions that enhance patient outcomes and improve healthcare efficiency.

Products and Services
  • Knee and hip implants for joint reconstruction
  • Advanced wound management solutions for acute and chronic wounds
  • Comprehensive sports medicine products for minimally invasive surgeries
Growth Outlook
  • Projected revenue growth driven by increasing demand for joint replacement surgeries
  • Expansion in emerging markets expected to enhance market share
  • Investment in R&D to foster innovation and product development
Financial Highlights
  • Q2 2026 revenue of $3.07 billion, reflecting strong market performance
  • Net income of $300.5 million, showcasing effective cost management
  • TTM gross profit margin of 68.18%, indicating robust operational efficiency
Smith & Nephew plc has established itself as a prominent player in the medical devices industry, with a diverse portfolio that addresses critical healthcare needs. The company's commitment to innovation and quality is evident in its extensive range of products, which cater to various medical specialties. Recent financial performance highlights a strong revenue base and effective cost management strategies, positioning the company for continued growth. The outlook remains positive, with anticipated expansion in emerging markets and ongoing investments in research and development. This combination of factors makes Smith & Nephew an intriguing option for potential investors interested in the healthcare sector.
AI Generated • Aug 29, 2026

Industry

Healthcare Equipment and Supplies

Employees

18,362

CEO

Deepak S Nath, PhD

Headquarters

Watford, HRT WD18 8YE, GB

SN Financials

Key Financial Metrics (TTM)

Gross Margin

68.18%

Operating Margin

16.69%

Net Income Margin

10.08%

Return on Equity

12.25%

Return on Capital

11.88%

Return on Assets

5.81%

Earnings Yield

N/A

Dividend Yield

2.76%

Payout Ratio

52.32%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$8.53B

Operating Income

$1.83B

EBITDA

$3.10B

Operating Cash Flow

$2.48B

Capital Expenditure

-$828.54M

Free Cash Flow

$1.65B

Cash & ST Invst.

$757.91M

Total Debt

$3.80B

Smith & Nephew Plc Performance Analysis

Smith & Nephew Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 4,233,709,94611.7%
20232023-12-31USD 4,464,013,3365.4%
20242024-12-31USD 4,546,833,6391.9%
20252025-12-31USD 4,677,172,4352.9%
Smith & Nephew Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.5%
Q22025-06-300.2%
Q42025-12-3110.6%
Q22026-06-30-7.1%
Smith & Nephew Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.21-52.2%
20232023-12-31USD 0.2416.9%
20242024-12-31USD 0.3751.9%
20252025-12-31USD 0.5447.6%
Smith & Nephew Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-8.0%
Q22025-06-3047.8%
Q42025-12-3114.7%
Q22026-06-30-10.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.07B

+8.7%

Gross Profit

$2.18B

+10.3%

Gross Margin

70.91%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

18,362

N/A

Net Income

$300.52M

+40.4%

EBITDA

$772.62M

+48.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$757.91M

+33.4%

Total Debt

$3.80B

+4.1%

Accounts Receivable

$1.53B

+12.8%

Inventory

$2.12B

-14.7%

Long Term Debt

$3.23B

-1.4%

Short Term Debt

$575.97M

+51.6%

Return on Assets

5.81%

N/A

Return on Invested Capital

11.81%

N/A

Free Cash Flow

$257.87M

+290.7%

Operating Cash Flow

$446.31M

+87.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CTEC.LConvaTec Group Plc
£2.27-2.65%
EKF.LEKF Diagnostics Holdings plc
£0.25+0.00%
RUA.LRUA Life Sciences plc
£0.27+0.00%
NCYT.LNovacyt S.A.
£0.44-2.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
IBITiShares Bitcoin Trust
$46.35+0.06%

Questions About SN

What is the current price of Smith & Nephew Plc?

Smith & Nephew Plc is trading at N/A per share.

What is the 52-week range for Smith & Nephew Plc?

Over the past 52 weeks, Smith & Nephew Plc has traded between N/A and N/A.

How much debt does Smith & Nephew Plc have?

As of the most recent reporting period, Smith & Nephew Plc reported total debt of $2.47B.

How much cash does Smith & Nephew Plc have on hand?

Smith & Nephew Plc reported $414.11M in cash and cash equivalents in its most recent financial results.

What is Smith & Nephew Plc’s dividend yield?

Smith & Nephew Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.